FDA Panel to Review Seven Peptides Amid Rising Popularity

A U.S. FDA advisory panel is set to review seven popular peptides to determine if they can be compounded by licensed pharmacies. Despite potential regulatory hurdles, industry experts anticipate continued strong consumer demand for these substances.

22 Jul, 12:33 — 22 Jul, 12:33

Post Share

Sources

Showing 1 of 1 sources

cbcHigh38d ago

U.S. FDA panel to review 7 peptides amid growing popularity

U.S. FDA advisers this week will weigh whether seven popular peptides can be compounded by licensed pharmacies, but even if regulators decline to expand access, industry participants say consumer demand is likely to remain strong.

Read full article →

PERSPECTA

PERSPECTA

FDA Panel to Review Seven Peptides Amid Rising Popularity

Sources

U.S. FDA panel to review 7 peptides amid growing popularity

Related Stories

Critics Hail Highly Rated Stephen King Adaptation and New Netflix Horror Releases

NASA Prepares to Launch Nancy Grace Roman Space Telescope

Serbia Inaugurates First Humanoid Robot Manufacturing Plant in Šabac

Chinese Chipmaker CXMT Sues Pentagon Over Military Blacklist Designation

PERSPECTA